Clinical characteristics and surgical outcomes following cardiac myxoma resection.

IF 1.2 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS
Journal of Cardiovascular and Thoracic Research Pub Date : 2025-03-18 eCollection Date: 2025-03-01 DOI:10.34172/jcvtr.025.33237
Nootan Hadiya, Madhur Kumar, Rimy Parshad, Poorna Chandar, Anubhav Gupta
{"title":"Clinical characteristics and surgical outcomes following cardiac myxoma resection.","authors":"Nootan Hadiya, Madhur Kumar, Rimy Parshad, Poorna Chandar, Anubhav Gupta","doi":"10.34172/jcvtr.025.33237","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Cardiac myxomas are the most common primary cardiac neoplasm (30-50%) with clinical incident of 0.5/ million population. Tranthoracic echocardiography remains the investigation of choice. Surgical excision is curative. The present study aims to analyze demographic and clinical characteristics as well as surgical outcomes in terms of mortality and recurrence of cardiac myxoma.</p><p><strong>Methods: </strong>Thirty patients of cardiac myxoma who met the inclusion criteria during study period study period, January-2018 to April-2024 were included. Data was analyzed for demographic characteristics, echocardiographic findings of myxoma and associated valve lesion, associated valve surgery and survival outcome.</p><p><strong>Results: </strong>Of all subjects, 83.33% presented with dyspnea. Majority of myxoma, 76.67% were attached to interatrial septum. Overall survival at 1- and 3- year was 91.23%. Recurrence free survival at 1-, 3- years and end of this study were 100%, 84.71% and 84.71% respectively. Myxomas with valvular incompetence are rare entity and there is paucity of data and evidences recommending concomitant valve intervention in such cases. There were no immediate peri-operative deaths, however, in contrast to other studies; surgical site infection was the most common post operative complication. Overall survival at 1- and 3- year was 91.23%. Recurrence free survival at 1-, 3- years and end of this study were 100%, 84.71% and 84.71% respectively. Recurrence occurred in first- and third-year following surgery.</p><p><strong>Conclusion: </strong>Study highlights decent outcomes following cardiac myxoma resection. Case specific concomitant valve intervention spiral the success of surgery.</p>","PeriodicalId":15207,"journal":{"name":"Journal of Cardiovascular and Thoracic Research","volume":"17 1","pages":"35-39"},"PeriodicalIF":1.2000,"publicationDate":"2025-03-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12068802/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Cardiovascular and Thoracic Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.34172/jcvtr.025.33237","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/3/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Cardiac myxomas are the most common primary cardiac neoplasm (30-50%) with clinical incident of 0.5/ million population. Tranthoracic echocardiography remains the investigation of choice. Surgical excision is curative. The present study aims to analyze demographic and clinical characteristics as well as surgical outcomes in terms of mortality and recurrence of cardiac myxoma.

Methods: Thirty patients of cardiac myxoma who met the inclusion criteria during study period study period, January-2018 to April-2024 were included. Data was analyzed for demographic characteristics, echocardiographic findings of myxoma and associated valve lesion, associated valve surgery and survival outcome.

Results: Of all subjects, 83.33% presented with dyspnea. Majority of myxoma, 76.67% were attached to interatrial septum. Overall survival at 1- and 3- year was 91.23%. Recurrence free survival at 1-, 3- years and end of this study were 100%, 84.71% and 84.71% respectively. Myxomas with valvular incompetence are rare entity and there is paucity of data and evidences recommending concomitant valve intervention in such cases. There were no immediate peri-operative deaths, however, in contrast to other studies; surgical site infection was the most common post operative complication. Overall survival at 1- and 3- year was 91.23%. Recurrence free survival at 1-, 3- years and end of this study were 100%, 84.71% and 84.71% respectively. Recurrence occurred in first- and third-year following surgery.

Conclusion: Study highlights decent outcomes following cardiac myxoma resection. Case specific concomitant valve intervention spiral the success of surgery.

心脏黏液瘤切除术后的临床特点及手术效果。
简介:心脏黏液瘤是最常见的原发性心脏肿瘤(30-50%),临床发病率为0.5/百万人。经胸超声心动图仍是研究的选择。手术切除可治愈。本研究旨在分析心脏黏液瘤的人口学和临床特征以及手术结果在死亡率和复发率方面的影响。方法:纳入2018年1月至2024年4月研究期间符合纳入标准的心脏黏液瘤患者30例。数据分析的人口学特征,超声心动图发现黏液瘤和相关瓣膜病变,相关瓣膜手术和生存结果。结果:83.33%的患者出现呼吸困难。绝大多数黏液瘤(76.67%)附着于房间隔。1年和3年的总生存率为91.23%。1年、3年和研究结束时的无复发生存率分别为100%、84.71%和84.71%。黏液瘤合并瓣膜功能不全是一种罕见的疾病,缺乏相关资料和证据建议对此类病例进行联合瓣膜介入治疗。然而,与其他研究相比,没有立即的围手术期死亡;手术部位感染是最常见的术后并发症。1年和3年的总生存率为91.23%。1年、3年和研究结束时的无复发生存率分别为100%、84.71%和84.71%。术后1年和3年复发。结论:研究强调心脏黏液瘤切除术后的良好结果。病例特异性联合螺旋瓣介入手术成功率高。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of Cardiovascular and Thoracic Research
Journal of Cardiovascular and Thoracic Research CARDIAC & CARDIOVASCULAR SYSTEMS-
CiteScore
2.00
自引率
0.00%
发文量
22
审稿时长
7 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信